Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.CA1 -- National Cancer Institute Research - Research Projects
Open opportunityLast Updated: Nov 3, 2026
Important dates
- Closing: November 16, 2029
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-28-042
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: November 3, 2026
- Archive date: January 15, 2030
- Version: 1
Summary
Jump to documentsThe purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers and markers of toxicity. Utilizing either a phased UH2/UH3 or a standalone UH3 mechanism, funding will facilitate laboratory optimization and clinical validation of assays that work on human samples and address a clearly defined cancer-related clinical need within a well-specified intended use.
Eligibility
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Government
- Federally recognized Native American tribal governments
- City or township governments
- State governments
- Public and Indian housing authorities
- Special district governments
- County governments
Business
- Small businesses
- For-profit organizations other than small businesses
Nonprofit
- Nonprofits non-higher education with 501(c)(3)
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
Miscellaneous
- Other
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-28-042-Full-Announcement.html | PAR-28-042-Full-Announcement.html | Nov 3, 2026 06:09 PM UTC |
Agency contact information
Email: NCICDPNOFO@mail.nih.gov
NCICDPNOFO@mail.nih.gov
Link to additional information
No additional information is available
